LiveWire

Rocket Lab, which got its start in New Zealand, and which still launches rockets there with its HQ now shifted to LA, will have a pro forma enterprise value of $4.1 billion via the transaction, with a total cash balance of $750 million once the deal goes through thanks to a PIPE of $470 million with funds invested via Vector, BlackRock and others. At close, existing Rocket Lab shareholders will retain 82% of the total equity in the combined company. Source: Yahoo

Looking at today's chart from Bespoke Investment Group, we see that days where the NASDAQ was down 2% or more while the less-tech-driven Dow Jones was up are mainly clustered around the 2000-2001 dotcom bubble. The question is: should we expect the same to happen soon? Rather not. Of course, the Dow will tend to outperform tech stocks in the coming months as it will be much more sensible to the economy reopening. But very strong GDP and earnings growth will continue to push stocks up. Tech valuations are high but not as absurd as in 2000. Remember that at that time, the US 10-year treasury yield was at 6%. According to Robeco Analyst Jeroen Blokland, the Dow will continue to make highs, while tech stocks will stay a little behind. 

66% of fixed broadband subscriptions are DSL and cabled internet connections, but high-speed fiber continues to make progress. Fiber now represents 29.2%, up from 12% only 9 years ago. South Korea is far ahead with a 83.9%, closely followed by Japan with 80.8%.

The MSCI Europe Index captures large and mid cap representations of 15 countries with developed markets in Europe. In the last year, unprofitable tech stock prices have clearly surpassed the MSCI's performance, although they seem to enter a downwards motion in the last week. 

Drugmakers that target the endocannabinoid system -- which is believed to play a key role in regulating body weight and controlling energy balance -- have skyrocketed in 2021. While those biotechs wouldn’t necessarily benefit from any legislative push for the pot industry, analysts say the stocks have jumped on the idea that they would be associated somehow with cannabis. And they are not. Tilray, Sundial Growers , Corbus, Artelo, Zynerba. Source: Bloomberg